Drug Trial Radar · NCT07613866
A Clinical Trial of HRS-3095 in Patients With Chronic Spontaneous Urticaria
Last checked: Nov 20, 2026Latest source record: May 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
190
Planned (sponsor's estimate)
Start
Jul 2026
Primary completion
Dec 2026
Study completion Mar 2027
Sponsor
- Lead sponsor
- Chengdu Suncadia Medicine Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- May 29, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is being conducted to evaluate the efficacy, and safety of HRS-3095 with Chronic Spontaneous in adults, and to explore the reasonable dosage of HRS-3095 for Chronic Spontaneous Urticaria.
Conditions
- Chronic Spontaneous Urticaria
Interventions
HRS-3095 TabletDrug
HRS-3095 tablet.
HRS-3095 Tablet PlaceboDrug
HRS-3095 tablet placebo.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Weekly Urticaria Activity Score (UAS7) from baseline at Week 4.Time frame: Up to 4 weeks.
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Huashan Hospital Affiliated to Fudan University
Shanghai, Shanghai Municipality, China
Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University
Hangzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.